These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29172032)

  • 1. Galactomannan use in clinical practice: providing free testing is not the full answer.
    Dos Santos JS; Hermes DM; Pasqualotto AC
    Braz J Infect Dis; 2018; 22(1):37-40. PubMed ID: 29172032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of galactomannan detection in the diagnosis and follow-up of hematological patients with invasive aspergillosis].
    Moragues MD; Amutio E; García-Ruiz JC; Pontón J
    Rev Iberoam Micol; 2003 Sep; 20(3):103-10. PubMed ID: 15456366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of serum galactomannan antigen testing combined with chest computed tomography for early diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies with febrile neutropenia after antifungal drug treatment.
    Wang X; Guo G; Cai R; He P; Zhang M
    J Int Med Res; 2019 Feb; 47(2):783-790. PubMed ID: 30477369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation.
    Ardi P; Daie-Ghazvini R; Hashemi SJ; Salehi MR; Bakhshi H; Rafat Z; Zareei M; Getso M; Basiri S; Sarwestani HK; Boroujeini ZB; Ahmadikia K
    Microb Pathog; 2020 Oct; 147():104382. PubMed ID: 32663605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients].
    Xie LP; Liu T; Meng WT; Zhou J
    Zhonghua Nei Ke Za Zhi; 2006 Dec; 45(12):992-5. PubMed ID: 17326997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?
    Gerard R; Gabriel F; Accoceberry I; Imbert S; Ducassou S; Angoso M; Jubert C
    Mycoses; 2024 Jul; 67(7):e13764. PubMed ID: 38970226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.
    Duarte RF; Sánchez-Ortega I; Cuesta I; Arnan M; Patiño B; Fernández de Sevilla A; Gudiol C; Ayats J; Cuenca-Estrella M
    Clin Infect Dis; 2014 Dec; 59(12):1696-702. PubMed ID: 25165088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based Aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: a randomized controlled trial.
    Aguado JM; Vázquez L; Fernández-Ruiz M; Villaescusa T; Ruiz-Camps I; Barba P; Silva JT; Batlle M; Solano C; Gallardo D; Heras I; Polo M; Varela R; Vallejo C; Olave T; López-Jiménez J; Rovira M; Parody R; Cuenca-Estrella M; ; ; ;
    Clin Infect Dis; 2015 Feb; 60(3):405-14. PubMed ID: 25336623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
    Pazos C; Pontón J; Del Palacio A
    J Clin Microbiol; 2005 Jan; 43(1):299-305. PubMed ID: 15634986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic-driven antifungal therapy in neutropenic patients using the D-index and serial serum galactomannan testing.
    Garnica M; Sinhorelo A; Madeira L; Portugal R; Nucci M
    Braz J Infect Dis; 2016; 20(4):354-9. PubMed ID: 27280789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of the Aspergillus galactomannan antigen testing for neutropenic paediatric patients.
    Sav H; Atalay MA; Koc AN; Unal E; Demir G; Zararsiz G
    Infez Med; 2017 Mar; 25(1):38-44. PubMed ID: 28353454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies.
    Ulusakarya A; Chachaty E; Vantelon JM; Youssef A; Tancrède C; Pico JL; Bourhis JH; Fenaux P; Munck JN
    Hematol J; 2000; 1(2):111-6. PubMed ID: 11920178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis.
    Koo S; Bryar JM; Baden LR; Marty FM
    J Clin Microbiol; 2010 Apr; 48(4):1255-60. PubMed ID: 20147646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of Aspergillus galactomannan antigen detection in the diagnosis and follow-up of invasive aspergillosis in hematological patients].
    Jarque I; Andreu R; Salavert M; Gómez D; Pemán J; Gobernado M; Sanz MA
    Rev Iberoam Micol; 2003 Sep; 20(3):116-8. PubMed ID: 15456368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial.
    Morrissey CO; Chen SC; Sorrell TC; Milliken S; Bardy PG; Bradstock KF; Szer J; Halliday CL; Gilroy NM; Moore J; Schwarer AP; Guy S; Bajel A; Tramontana AR; Spelman T; Slavin MA;
    Lancet Infect Dis; 2013 Jun; 13(6):519-28. PubMed ID: 23639612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of galactomannan and beta-d-glucan assays for the diagnosis of invasive aspergillosis in clinically suspected cases.
    Sarwar M; Gardezi SAH; Zaman G; Ikram A; Satti L; Khadim MT
    J Pak Med Assoc; 2020 Mar; 70(3):442-446. PubMed ID: 32207422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
    Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
    Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp.
    Guinea J; Jensen J; Peláez T; Gijón P; Alonso R; Rivera M; Muñoz P; Bouza E
    Med Mycol; 2008 Sep; 46(6):575-9. PubMed ID: 19180751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.